Our vision is a world where every person, everywhere benefits from timely access to safe, effective, and quality-assured medicines and other health products, including innovative products and emerging technologies, to attain the highest possible level of health and well-being.
Our mission is to facilitate access to safe, effective and quality-assured medicines and health products to achieve universal health coverage goals through the provision of evidence-based normative guidance, standards, specifications, policy and technical assistance to Member States. The scope of our work covers assistive technology; biologicals and biological products (including cell and gene therapies); blood products; internationally-controlled medicines and substances; medical devices, including in vitro diagnostics; medicines; and organs, tissues and cell transplantation.
Contact information
Featured
News
All →Expert Committees
Advisory groups
Databases
Publications
All →Journal articles
Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards
The global distribution and burden of dengue
The Digital and Assistive Technologies for Ageing initiative: learning from the GATE initiative
Meeting reports
Uzbekistan: Reimbursatsiya dasturiga kiritiladigan kasalliklar va ularni davolashda beriladigan dori vositalari roʻyxatini tasdiqlash to‘g‘risida 2026 (Uzbek)
South Africa: Essential Medicines List 2024 (English)
INN Recommended List 96
Nigeria: Essential Medicines list 2024 (English)
United Republic of Tanzania: National Essential Medicines List (NEMLIT) 2026 (English)
Executive Summary of the WHO Implementation Workshop in the Western Pacific region: Revised WHO Guidelines on Evaluation of Biosimilars
Trainings
Multimedia